Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | BTN3A1 | O00481 | 7/20 | 0.36 |
| ▸ | POLRMT | O00411 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10149560 | 0.92 | CYP3A4 (0.51) | CYP3A4CYP2C9BTN3A1POLRMT | |
| SCHEMBL12067528 | 0.91 | CYP3A4 (0.40) | CYP3A4CYP2C9BTN3A1 | |
| SCHEMBL15898741 | 0.90 | CYP3A4 (0.44) | CYP3A4CYP2C9BTN3A1POLRMT | |
| SCHEMBL21283660 | 0.88 | CYP3A4 (0.42) | CYP3A4CYP2C9BTN3A1POLRMT | |
| SCHEMBL12067504 | 0.88 | CYP3A4 (0.44) | CYP3A4CYP2C9BTN3A1 | |
| SCHEMBL12067503 | 0.88 | CYP3A4 (0.44) | CYP3A4CYP2C9BTN3A1 | |
| SCHEMBL13667500 | 0.87 | CYP3A4 (0.45) | CYP3A4CYP2C9BTN3A1POLRMT | |
| SCHEMBL10171209 | 0.86 | CYP3A4 (0.41) | CYP3A4CYP2C9BTN3A1POLRMT | |
| SCHEMBL881567 | 0.86 | CYP3A4 (0.41) | CYP3A4CYP2C9BTN3A1POLRMT | |
| SCHEMBL21284203 | 0.86 | CYP3A4 (0.42) | CYP3A4CYP2C9BTN3A1POLRMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012012465-A1 | METHODS FOR THE PREPARATION OF DIASTEROMERICALLY PURE PHOSPHORAMIDATE PRODRUGS | CLARKE, MICHAEL, O'NEIL HANRAHAN (US) | 2012-01-26 | — | — | WO | disclosed |